Randomized Phase III Comparison of Standard Dose (60Gy) Versus High-Dose (74Gy) Conformal Chemoradiotherapy +/- Cetuximab for Stage IIIA/B Non-Small Cell Lung Cancer: Preliminary Findings on Radiation Dose in RTOG 0617

Reporter: Surbhi Grover, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 3 de octubre del 2011

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

EGFR Level Predicts Survival Benefit of Cetuximab in NSCLC

Nov 7, 2011

Patients with high EGFR expression survive longer if they receive cetuximab in addition to chemo

Cetuximab May Improve Survival in Advanced Lung Cancer

Nov 26, 2015

FLEX study shows improved survival with cetuximab and chemo versus chemo alone

Dose-Escalated Cetuximab Tolerated in Colorectal Cancer

Jul 6, 2012

Possible improved response and disease control rates in irinotecan-refractory metastatic CRC

Frequently Asked Questions